Position in CERS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$270,550
-$37,269 QoQ
Shares Held
148,654
-0.5% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $6,476,872,734 across 48 Medical Devices names. CERS ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
20,022,905 | $2,055,751,650 | |
| 2 | MDT |
Medtronic plc
|
14,175,679 | $1,228,322,578 | |
| 3 | SYK |
Stryker Corp
|
2,786,054 | $915,469,478 | |
| 4 | BSX |
Boston Scientific Corp
|
14,498,741 | $909,795,995 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
5,452,665 | $493,029,963 | |
| 6 | STE |
STERIS plc
|
1,242,625 | $274,781,663 | |
| 7 | DXCM |
Dexcom Inc
|
2,607,438 | $163,747,102 | |
| 8 | BRKR |
Bruker Corp
|
2,919,177 | $105,440,670 |
All Filings in CERS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $270,550 | 148,654 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $307,819 | 149,427 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $50,178 | 31,559 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $130,242 | 93,700 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $160,048 | 103,928 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $163,147 | 93,763 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $145,067 | 82,425 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $155,971 | 82,525 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||